Skip to content
AnalystLens

Archer-Daniels-Midland Annual Report, Year Ended Dec 31, 2025

Filing Date
Filed February 17, 2026
Period End
December 31, 2025
Security
ADM
In the record · 2016–202610-K1210-Q368-K102

ADM filed 12 annual reports (10-K), 36 quarterly reports (10-Q) and 102 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Nov ’22Nov ’22
  2. Leadership change8-K · Jan ’25Jan ’25

Summary

Summary of the 10-K filed February 17, 2026. Cited figures are marked; the original filing is the authoritative source.

Archer-Daniels-Midland Company (ADM) reported a challenging year for the fiscal year ending December 31, 2025.

While revenues saw a decrease of $5.3 billion to $80.3 billiona, driven by lower sales volumes and prices across segments, the company's focus remains on strategic priorities including operational excellence, cost management, and targeted growth investments. The Ag Services and Oilseeds segment experienced compressed margins due to increased global supplies, policy uncertainties, and logistical issues, leading to a significant decline in segment operating profit. The Carbohydrate Solutions segment also saw a decrease in operating profit, influenced by lower ethanol and starch margins and higher manufacturing costs.

However, the Nutrition segment demonstrated resilience, with a modest increase in segment operating profit, driven by growth in the Flavors market and expansion opportunities in dietary supplements, despite facing challenges from tariffs and inflation. ADM is actively pursuing cost savings, targeting over $500 millionb in cumulative savings over the next three to five years through cost optimization and portfolio simplification. The company made several strategic portfolio actions in 2025, including acquisitions and the formation of joint ventures to enhance its market position.

Despite a decrease in earnings before income taxes by 44% year-over-year, largely due to significant impairment charges and equity method investment impacts, ADM maintains a strong liquidity position with $10.4 billionc in total available liquidity. The company reiterated its commitment to disciplined capital deployment, including dividends, and is investing in future growth areas such as enhanced nutrition, biotics, and biosolutions.

Key Highlights

  1. Revenues decreased by $5.3 billion to $80.3 billion in 2025 due to lower volumes and prices.
  2. Ag Services and Oilseeds segment operating profit declined by 34% ($833 million) due to compressed margins and logistical challenges.
  3. Nutrition segment operating profit increased by 8% ($31 million), showing resilience, particularly in the Human Nutrition subsegment.
  4. ADM announced targeted actions expected to deliver over $500 million in cumulative cost savings within 3-5 years.
  5. The company recorded significant impairment charges totaling $372 million related to alternative protein investments and $179 million for capitalized software.
  6. Despite a 44% decrease in earnings before income taxes, ADM maintained strong liquidity with $10.4 billion in available liquidity as of December 31, 2025.
  7. Capital expenditures were $1.2 billion in 2025, with planned expenditures of approximately $1.4 billion for 2026.

Financial Statements

FY2025 against FY2024

Line itemFY2025FY2024Change
Revenue$80.27B$85.53B−6.2%
Cost of Revenue$75.24B$79.75B−5.7%
Gross Profit$5.03B$5.78B−12.9%
R&D Expenses$246.00M$269.00M−8.6%
SG&A Expenses$3.61B$3.71B−2.6%
Interest Expense$612.00M$706.00M−13.3%
Net Income$1.08B$1.80B−40.1%
EPS (Basic)$2.23$3.66−39.1%
EPS (Diluted)$2.23$3.65−38.9%
Shares Outstanding (Basic)484.00M492.00M−1.6%
Shares Outstanding (Diluted)484.00M493.00M−1.8%

Frequently Asked Questions

  1. What were the main drivers of ADM's revenue decrease in 2025?

    ADM's revenue decreased by $5.3 billion to $80.3 billion in 2025, primarily driven by a combination of lower sales volumes ($2.9 billion) and lower sales prices ($2.3 billion) across its key segments, particularly in Ag Services and Oilseeds, and Carbohydrate Solutions.

  2. How did ADM's segments perform in 2025?

    The Ag Services and Oilseeds segment saw a significant decrease in operating profit (34%) due to compressed margins and logistical issues. Carbohydrate Solutions segment operating profit decreased by 12%, influenced by lower margins and higher manufacturing costs. The Nutrition segment, however, showed growth, with an 8% increase in operating profit, driven by strong performance in the Human Nutrition subsegment.

  3. What is ADM's strategy to improve financial performance and drive future growth?

    ADM's strategy focuses on operational excellence and cost management, aiming for over $500 million in cumulative cost savings through initiatives like boosting plant efficiencies and optimizing operating leverage. They are also pursuing strategic simplification of their portfolio and investing in targeted growth areas such as plant modernization, advanced nutrition, and biosolutions.

  4. What is ADM's current financial health and liquidity position?

    As of December 31, 2025, ADM reported total available liquidity of $10.4 billion, comprising cash and cash equivalents and unused lines of credit. The company believes these resources are sufficient to meet its liquidity requirements for at least the next twelve months. Despite a decrease in earnings before income taxes, the company's balance sheet and access to credit markets remain strong.